These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15689175)

  • 21. Synthesis and phospholipase A2 inhibitory activity of thielocin B3 derivatives.
    Teshirogi I; Matsutani S; Shirahase K; Fujii Y; Yoshida T; Tanaka K; Ohtani M
    J Med Chem; 1996 Dec; 39(26):5183-91. PubMed ID: 8978846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on inhibitors of human 14 kDa Type II s-PLA2 in development.
    Springer DM
    Curr Pharm Des; 2001 Feb; 7(3):181-98. PubMed ID: 11311112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity.
    Hansford KA; Reid RC; Clark CI; Tyndall JD; Whitehouse MW; Guthrie T; McGeary RP; Schafer K; Martin JL; Fairlie DP
    Chembiochem; 2003 Mar; 4(2-3):181-5. PubMed ID: 12616631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
    Fleisch JH; Armstrong CT; Roman CR; Mihelich ED; Spaethe SM; Jackson WT; Bobbitt JL; Draheim S; Bach NJ; Dillard RD; Martinelli M; Fouts R; Snyder DW
    J Pharmacol Exp Ther; 1996 Jul; 278(1):252-7. PubMed ID: 8764358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
    Glaser KB; de Carvalho MS; Jacobs RS; Kernan MR; Faulkner DJ
    Mol Pharmacol; 1989 Nov; 36(5):782-8. PubMed ID: 2586492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists.
    Burkholder TP; Cunningham BE; Clayton JR; Lander PA; Brown ML; Doti RA; Durst GL; Montrose-Rafizadeh C; King C; Osborne HE; Amos RM; Zink RW; Stramm LE; Burris TP; Cardona G; Konkol DL; Reidy C; Christe ME; Genin MJ
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1377-80. PubMed ID: 25752984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution.
    Wery JP; Schevitz RW; Clawson DK; Bobbitt JL; Dow ER; Gamboa G; Goodson T; Hermann RB; Kramer RM; McClure DB
    Nature; 1991 Jul; 352(6330):79-82. PubMed ID: 2062381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (E)-Phenyl- and -heteroaryl-substituted O-benzoyl-(or acyl)oximes as lipoprotein-associated phospholipase A2 inhibitors.
    Jeong TS; Kim MJ; Yu H; Kim KS; Choi JK; Kim SS; Lee WS
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1525-7. PubMed ID: 15713421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of 14-kDa PLA2 by 2-acylamino-alkylphospholipids: the influence of amide acidity.
    Kley JT; Unger C; Massing U
    Biochim Biophys Acta; 1998 Jun; 1392(2-3):193-201. PubMed ID: 9630626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of Ecopladib, an indole inhibitor of cytosolic phospholipase A2alpha.
    Lee KL; Foley MA; Chen L; Behnke ML; Lovering FE; Kirincich SJ; Wang W; Shim J; Tam S; Shen MW; Khor S; Xu X; Goodwin DG; Ramarao MK; Nickerson-Nutter C; Donahue F; Ku MS; Clark JD; McKew JC
    J Med Chem; 2007 Mar; 50(6):1380-400. PubMed ID: 17305324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
    Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
    J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of secreted phospholipase A2. 4-glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities.
    Touaibia M; Djimdé A; Cao F; Boilard E; Bezzine S; Lambeau G; Redeuilh C; Lamouri A; Massicot F; Chau F; Dong CZ; Heymans F
    J Med Chem; 2007 Apr; 50(7):1618-26. PubMed ID: 17335183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melittin binds to secretory phospholipase A2 and inhibits its enzymatic activity.
    Saini SS; Peterson JW; Chopra AK
    Biochem Biophys Res Commun; 1997 Sep; 238(2):436-42. PubMed ID: 9299527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemically modified non-antimicrobial tetracyclines inhibit activity of phospholipases A2.
    Pruzanski W; Stefanski E; Vadas P; McNamara TF; Ramamurthy N; Golub LM
    J Rheumatol; 1998 Sep; 25(9):1807-12. PubMed ID: 9733464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution X-ray crystallography reveals precise binding interactions between human nonpancreatic secreted phospholipase A2 and a highly potent inhibitor (FPL67047XX).
    Cha SS; Lee D; Adams J; Kurdyla JT; Jones CS; Marshall LA; Bolognese B; Abdel-Meguid SS; Oh BH
    J Med Chem; 1996 Sep; 39(20):3878-81. PubMed ID: 8831753
    [No Abstract]   [Full Text] [Related]  

  • 36. Quinoline-4-methyl esters as human nonpancreatic secretory phospholipase A₂ inhibitors.
    Wu Y; Chen Z; Liu Y; Yu L; Zhou L; Yang S; Lai L
    Bioorg Med Chem; 2011 Jun; 19(11):3361-6. PubMed ID: 21555224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1-(5-Carboxy- and 5-carbamoylindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: bioisosteric replacement of the carboxylic acid and carboxamide moiety.
    Hess M; Schulze Elfringhoff A; Lehr M
    Bioorg Med Chem; 2007 Apr; 15(8):2883-91. PubMed ID: 17320401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based design of a new class of anti-inflammatory drugs: secretory phospholipase A(2) inhibitors, SPI.
    Mihelich ED; Schevitz RW
    Biochim Biophys Acta; 1999 Nov; 1441(2-3):223-8. PubMed ID: 10570250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formal homo-Nazarov and other cyclization reactions of activated cyclopropanes.
    De Simone F; Saget T; Benfatti F; Almeida S; Waser J
    Chemistry; 2011 Dec; 17(51):14527-38. PubMed ID: 22113928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of secretory phospholipase A2. 1-design, synthesis and structure-activity relationship studies starting from 4-tetradecyloxybenzamidine to obtain specific inhibitors of group II sPLA2s.
    Assogba L; Ahamada-Himidi A; Habich NM; Aoun D; Boukli L; Massicot F; Mounier CM; Huet J; Lamouri A; Ombetta JE; Godfroid JJ; Dong CZ; Heymans F
    Eur J Med Chem; 2005 Sep; 40(9):850-61. PubMed ID: 16084626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.